Unspecified primary angle-closure glaucoma digital illustration

Unspecified primary angle-closure glaucoma Save


ICD-10 code: H40.20

Chapter: Diseases of the eye and adnexia

Understanding Unspecified Primary Angle-Closure Glaucoma

Unspecified primary angle-closure glaucoma is a type of eye disease that affects the drainage system of the eye, leading to increased pressure inside the eye. This condition is a result of the angle between the cornea and iris becoming narrow, which can cause the iris to block the drainage channels. This blockage can result in the buildup of fluid in the eye, leading to optic nerve damage and vision loss.

  1. Symptoms: The symptoms of unspecified primary angle-closure glaucoma can include severe eye pain, headache, blurred vision, redness of the eye, and halos around lights.
  2. Diagnosis: A comprehensive eye exam, including a visual field test and high-resolution imaging of the optic nerve, can help diagnose this condition.
  3. Treatment: Early diagnosis and treatment are essential for managing unspecified primary angle-closure glaucoma. Treatment may include medications to reduce intraocular pressure, laser treatment, or surgery to create a new drainage channel for the fluid in the eye.

If left untreated, unspecified primary angle-closure glaucoma can lead to irreversible vision loss. It is essential to schedule regular eye exams with an eye doctor to monitor the health of your eyes and detect any potential issues early on. Additionally, maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help reduce the risk of developing eye diseases like glaucoma.

In conclusion, unspecified primary angle-closure glaucoma is a serious eye condition that can lead to vision loss if not diagnosed and treated promptly. Understanding the symptoms, diagnosis, and treatment options can help individuals manage this condition and preserve their vision. If you are experiencing any symptoms of glaucoma, schedule an appointment with your eye doctor as soon as possible.